Ignite Creation Date:
2025-12-24 @ 5:20 PM
Ignite Modification Date:
2025-12-31 @ 1:31 AM
Study NCT ID:
NCT01662050
Status:
COMPLETED
Last Update Posted:
2022-08-09
First Post:
2012-06-26
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Phase II Study of Age-Adjusted Rituximab, Bendamustine, Cytarabine as Induction Therapy in Older Patients With MCL
Sponsor:
Fondazione Italiana Linfomi - ETS
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2012-03-20
Start Date Type:
ACTUAL
Primary Completion Date:
2014-08
Primary Completion Date Type:
ACTUAL
Completion Date:
2017-09-11
Completion Date Type:
ACTUAL
First Submit Date:
2012-06-26
First Submit QC Date:
None
Study First Post Date:
2012-08-10
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-08-08
Last Update Post Date:
2022-08-09
Last Update Post Date Type:
ACTUAL